Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Breast Pap Test Trial"

14:07 EDT 23rd July 2014 | BioPortfolio

Original Source: NeoMatrix, LLC

Based in Irvine, Calif., NeoMatrix© develops innovative devices that allow women and their doctors to promote optimal breast health. The company's premier product, the HALO Breast Pap Test System, is the first fully automated, noninvasive breast cancer risk assessment tool designed for use in the primary care office setting. The System has been FDA cleared for the collection of nipple aspirate fluid for cytological evaluation for the determination and/or differentiation of normal versus pre-malignant versu...

Matching Channels

Schilling test

Sniff test

Spirometry Test

The gold standard in lung testing In the same way that blood pressure measurements provide a simple yet effective screening method for cardiovascular disease, spirometry tests can help to unmask t...

Breast Lumps

OncoDEEP

At OncoDNA, our philosophy is to provide the most suitable test in terms of rapidity and cost. That’s why we follow a 3 tier approach to find tumour mutations which can respond to new cancer t...

Matching News

Euro Breast Ca: Breath Test, Cardiac Toxicity, Brain Mets (CME/CE)

(MedPage Today) -- A bedside breath test identified about 80% of patients with biopsy-proven breast cancer or abnormal mammograms, suggesting potential as a test to rule out breast cancer and possibly...

IU, Paradigm team up to test genomic sequencing for women with aggressive breast cancer

(Indiana University) Researchers at the Indiana University Melvin and Bren Simon Cancer Center are using targeted DNA sequencing in a new clinical trial for women with triple negative breast cancer, t...

Published study validates MammaPrint test for long-term prediction of breast cancer outcome

A newly published study concludes that the MammaPrint® breast cancer test can accurately stratify a woman's breast cancer risk for up to 25 years after she is first diagnosed with the disease. U.S...

Blood Test for Predicting Breast Cancer

A simple blood test is currently in development that could help predict the likelihood of a woman developing breast cancer A simple blood test is currently in development that could help predict the l...

[News] Epigenetic test for breast cancer

A new study has identified a blood-based epigenetic signature associated with breast cancer risk and mortality. The findings show the potential for an epigenetic test that could eventually be used to...

Breast cancer warning from blood test

Women with a predisposition to breast cancer could be warned of developing symptoms by a simple blood test even if they do not inherit genes associated with disease, scientists said on Friday. Researc...

Blood Test Aims to Predict Breast Cancer's Return

TUESDAY, April 15, 2014 -- A new blood test may one day help predict the recurrence of breast cancer and also a woman's response to breast cancer treatment, researchers report. "We are able to do this...

Breast cancer risk test 'promising'

A simple blood test could offer many women an early warning of breast cancer even if they do not inherit genes linked to the disease.

Matching PubMed Articles

Phase I/II Trial of Vinorelbine and Sorafenib in Metastatic Breast Cancer.

We investigated the efficacy and toxicity of sorafenib, a multikinase inhibitor of vascular endothelial growth factor receptor tyrosine kinase, in combination with vinorelbine therapy in a phase I/II...

The influence of chlorella and its hot water extract supplementation on quality of life in patients with breast cancer.

A self-control, randomized, and open-label clinical trial was performed to test the effects of the unicellular green algae Chlorella and hot water extract supplementation on quality of life (QOL) in p...

Positive Results for Drug Combo in I-SPY 2 Trial.

In results from one part of the I-SPY 2 trial announced at the 2013 San Antonio Breast Cancer Symposium, neoadjuvant veliparib plus carboplatin improved outcomes for women with triple-negative breast...

Breast cancer survivors willingness to participate in an acupuncture clinical trial: a qualitative study.

Acupuncture is a complementary and alternative medicine (CAM) modality that shows promise as a component of supportive breast cancer care. Lack of robust recruitment for clinical trial entry has limit...

Contralateral Prophylactic Mastectomy in the American College of Radiology Imaging Network 6667 Trial: Effect of Breast MR Imaging Assessments and Patient Characteristics.

Purpose To assess which patient and magnetic resonance (MR) imaging factors are associated with the likelihood of contralateral prophylactic mastectomy (CPM) in patients with newly diagnosed breast ca...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement